Learning opportunity: Continuing medical education activities are required in order for physicians to maintain licensing. Rarely do we patients get exposure to their learning materials. CLL Society has partnered with Clinical Care Options to develop an educational activity for healthcare providers who treat patients with CLL. This program features expert insight commentaries, an Interactive Treatment Decision Support Tool, and a series of micro-learning, micro-education modules. Not only will it help improve CLL care offered by healthcare providers, it can also help empower and engage patients to become informed participants in shared decision-making. Have a look around the CLL sections. Explore at your own pace. Learn more about "Optimizing Decision-Making in CLL in an Era of Novel Agents," and consider sharing with your healthcare providers. clinicaloptions.com/oncolog...
Learning opportunity: "Optimizing Decision-Mak... - CLL Support
Learning opportunity: "Optimizing Decision-Making in CLL in an Era of Novel Agents"/ What doctors are learning about treating CLL
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
1 Reply
•
Thanks Brian, education is definitely the best tool in the box for all of us with difficult decisions to make.
Not what you're looking for?
You may also like...
"Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma: unraveling CLL/SLL biological gray zone in the era of novel therapies
Encouraging news in this abstract from CLL/SLL researchers at the Northwestern Memorial Hospital,...
Worried About Going Back to Work?
Worried about going back to work? The CLL Society continues to urge all CLL patients to strictly...
New compendium of quality CLL resources for patients + your hematologist
I am sharing a collection of high quality CLL resources for both patients and hematologists....
Aussies and Kiwis with CLL - Your invitation to help researchers investigate what you value with respect to your care and management
Community and Patient Preference Research (CAPPRE), on behalf of a pharmaceutical company, is...
Treatment Tradeoffs. Very good Video. Debate: Is it appropriate to treat patients with CLL earlier in the era of novel agents? Dr. Furman
Published on Apr 23, 2017
In this presentation from the 2017 Great Debates & Updates in...